Journal article
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism
Abstract
Importance: Among patients younger than 21 years of age, the optimal duration of anticoagulant therapy for venous thromboembolism is unknown.
Objective: To test the hypothesis that a 6-week duration of anticoagulant therapy for provoked venous thromboembolism is noninferior to a conventional 3-month therapy duration in patients younger than 21 years of age.
Authors
Goldenberg NA; Kittelson JM; Abshire TC; Bonaca M; Casella JF; Dale RA; Halperin JL; Hamblin F; Kessler CM; Manco-Johnson MJ
Journal
JAMA: The Journal of the American Medical Association, Vol. 327, No. 2, pp. 129–137
Publisher
American Medical Association (AMA)
Publication Date
January 11, 2022
DOI
10.1001/jama.2021.23182
ISSN
0098-7484